InvestorsHub Logo
Followers 21
Posts 936
Boards Moderated 1
Alias Born 07/20/2020

Re: None

Tuesday, 01/16/2024 8:26:40 AM

Tuesday, January 16, 2024 8:26:40 AM

Post# of 36648
https://revivethera.com/2024/01/revive-therapeutics-provides-update-evaluating-bucillamine-for-nerve-agent-exposure-with-defence-research-and-development-canada/

Two things stand out. One- the short trial timetable: Two- The interest in Bucy as a tool for seizure prevention. Time will tell.